5-bromo-3-hydroxy-3-(pyridin-2-ylmethyl)-1H-indol-2-one

Names

[ CAS No. ]:
99304-31-1

[ Name ]:
5-bromo-3-hydroxy-3-(pyridin-2-ylmethyl)-1H-indol-2-one

Chemical & Physical Properties

[ Density]:
1.643g/cm3

[ Boiling Point ]:
525.5ºC at 760 mmHg

[ Molecular Formula ]:
C14H11BrN2O2

[ Molecular Weight ]:
319.15300

[ Flash Point ]:
271.6ºC

[ Exact Mass ]:
318.00000

[ PSA ]:
65.71000

[ LogP ]:
2.31160

[ Index of Refraction ]:
1.684

Toxicological Information

CHEMICAL IDENTIFICATION

RTECS NUMBER :
NM3257500
CHEMICAL NAME :
2H-Indol-2-one, 1,3-dihydro-5-bromo-3-hydroxy-3-(2-pyridinylmethyl)-
CAS REGISTRY NUMBER :
99304-31-1
LAST UPDATED :
199612
DATA ITEMS CITED :
1
MOLECULAR FORMULA :
C14-H11-Br-N2-O2
MOLECULAR WEIGHT :
319.18
WISWESSER LINE NOTATION :
T56 BMV DHJ DQ D1- BT6NTJ& GE

HEALTH HAZARD DATA

ACUTE TOXICITY DATA

TYPE OF TEST :
LD50 - Lethal dose, 50 percent kill
ROUTE OF EXPOSURE :
Intraperitoneal
SPECIES OBSERVED :
Rodent - mouse
DOSE/DURATION :
700 mg/kg
TOXIC EFFECTS :
Details of toxic effects not reported other than lethal dose value
REFERENCE :
PCJOAU Pharmaceutical Chemistry Journal (English Translation). Translation of KHFZAN. (Plenum Pub. Corp., 233 Spring St., New York, NY 10013) No.1- 1967- Volume(issue)/page/year: 19,562,1985

Synthetic Route


Related Compounds

  • 6-Chloro-2-(methylthio)pyrido[2,3-d]pyrimidin-7(1H)-one
  • N-(3-acetylphenyl)-2-(4-oxopyrido[3',2':4,5]thieno[3,2-d]pyrimidin-3(4H)-yl)acetamide
  • 2-[N-(3-methoxyphenyl)acetamido]acetic acid
  • [4-(4-Chlorophenyl)piperidin-4-yl]methanol
  • 3,3-Dimethyl-1-(4-nitrophenyl)piperazine
  • 2-(Methylthio)pyrido[2,3-d]pyrimidin-7-amine
  • 5-Bromo-2-chlorocinnamic acid
  • Ethyl 2-oxo-7-(((trifluoromethyl)sulfonyl)oxy)-2H-chromene-3-carboxylate
  • 2-(3-Ethylpentan-3-yl)phenol
  • [1-(3-Bromo-phenyl)-2-hydroxy-ethyl]-carbamic acid tert-butyl ester
The content on this webpage is sourced from various professional data sources. If you have any questions or concerns regarding the content, please feel free to contact service1@chemsrc.com.